Thymosin Alpha 1 For Sale

Description

What is Thymosin Alpha 1?

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid peptide derived from prothymosin alpha and originally isolated from the thymus gland as part of thymosin fraction-5. It was first identified and characterized in the late 1970s as a biologically active thymic peptide that regulates immune function.

Researchers describe Tα1 as an immunomodulatory peptide associated with immune activity, supporting its continued use in scientific and laboratory studies. In this context, Thymosin Alpha-1 for sale is intended strictly for research purposes and is not approved for human consumption.

Source: PubChem

How Does Thymosin Alpha 1 Work?

Thymosin Alpha-1 (Tα1) works by activating toll-like receptor 9 (TLR-9) pathways, regulating the immune response, and influencing key immune cells. It promotes the maturation of dendritic cells and enhances their function, supporting antigen presentation and the activation of T cells. Tα1 also increases the activity of natural killer cells, contributing to coordinated immune signaling.

At the molecular level, it regulates cytokine production, including IFN-γ and IL-2, and supports the activity of antioxidant enzymes, contributing to responses associated with oxidative stress and reactive oxygen species. These effects help maintain immune balance.

Findings from in vitro studies and murine models continue to define its potential role in immune processes. Thymosin Alpha-1 for sale is intended strictly for research purposes and is not approved for human consumption.

What Are the Potential Benefits of Thymosin Alpha 1?

Thymosin Alpha‑1 has been evaluated in clinical trials and experimental studies for its role in immune‑related conditions. It is a natural peptide derived from thymus tissue and identified as a naturally occurring peptide fragment with immunomodulatory activity. Research demonstrates the efficacy of Thymosin Alpha‑1 in conditions involving infection, malignancy, and immune dysfunction. Thymosin Alpha‑1 for sale meets the demand for this peptide in research‑focused investigations of immune‑related disorders.

Immune System Research

Studies show that Thymosin Alpha 1 modulates immune responses and promotes the proliferation of T lymphocytes. These effects are associated with improved immune resilience and support of the body’s natural defenses, with studies reporting changes in immune cell subsets in both preclinical and clinical settings.

Cancer Research

Studies demonstrate that Thymosin Alpha 1 has been evaluated in tumor models, including lung cancer cells, and influences cancer cells through immune-mediated mechanisms. Research also examines its effects on cellular proliferation, and cell migration, and its use in combination with immunotherapy approaches in cancer studies.

Infectious Disease and Viral Models

Studies have evaluated Thymosin Alpha 1 in viral infections, including chronic hepatitis, and hepatitis C, where it modulates antiviral immune responses. Clinical trials report activity in hepatitis-related conditions and immune response modulation in viral disease models.

Inflammation and Immune Balance

Studies indicate that Thymosin Alpha 1 regulates inflammatory responses and contributes to the control of immune activation. These effects are associated with the regulation of chronic inflammation, including cytokine-related changes observed in experimental models.

Advanced Research Models

Studies using systems such as the human lung epithelial adenocarcinoma cell line evaluate its effects on cellular signaling and apoptosis. These findings support its beneficial extrapulmonary effects and its role in systemic immune processes observed across multiple disease models.

Does Thymosin Alpha 1 Have Any Side Effects?

Thymosin Alpha-1 has been evaluated in clinical studies for its safety profile, where it has been consistently described as well tolerated, with a low incidence of adverse effects. Research across multiple trials reports no significant safety concerns in the studied populations.

The most commonly reported observations include mild local reactions at the injection site, such as redness or irritation. Some studies also describe occasional mild systemic symptoms, including fatigue, fever or nausea, while serious adverse events remain uncommon.

These findings support continued investigation of this peptide in controlled research. Thymosin Alpha 1 for sale is intended strictly for laboratory research-purposes and is not approved for human consumption.

Thymosin Alpha 1 Specifications

Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅

Molecular Weight: 3108.3 g/mol

Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser- Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH

Unit Quantity: 1 Vial

Appearance: White Powder

Peptide Purity: >99%

Discover premium quality Thymosin Alpha 1 For Sale from My Peptides. Our Thymosin Alpha 1 Peptide Vials are guaranteed 99% pure and are available in 10mg for research. Buy today!

Scientific Research

(1) Dominari A, Hathaway Iii D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Fahem MMM, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: A comprehensive review of the literature. World J Virol. 2020 Dec 15;9(5):67-78.

(2) King R, Tuthill C. Immune Modulation with Thymosin Alpha 1 Treatment. Vitam Horm. 2016;102:151-78.

(3) Wei Y, Zhang Y, Li P, Yan C, Wang L. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications. Int Immunopharmacol. 2023 Apr;117:109744.

(4) Tao N, Xu X, Ying Y, Hu S, Sun Q, Lv G, Gao J. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules. 2023 Apr 17;28(8):3539.

(5) Pica F, Chimenti MS, Gaziano R, Buè C, Casalinuovo IA, Triggianese P, Conigliaro P, Di Carlo D, Cordero V, Adorno G, Volpi A, Perricone R, Garaci E. Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. Clin Exp Immunol. 2016 Oct;186(1):39-45.

Frequently Asked Questions

Is Thymosin Alpha-1 FDA-approved?

The U.S. Food and Drug Administration has not approved Thymosin Alpha-1 for any indication. Clinical literature describes it as an investigational peptide studied in infections, cancer, and immune disorders. It remains in clinical trials and research use, and regulatory frameworks classify it as an unapproved drug in the United States despite ongoing therapeutic investigation.

What is the difference between Thymosin Alpha-1 and Thymalfasin?

Thymosin Alpha-1 is a naturally occurring thymic peptide composed of 28 amino acids, while thymalfasin is its synthetic version with the same sequence and biological activity. Studies confirm structural identity and use in clinical research settings. Thymalfasin provides a standardized formulation, whereas generic Thymosin Alpha-1 is commonly supplied for experimental or investigational purposes.

Can Thymosin Alpha-1 trigger an immune response?

Thymosin Alpha-1 activates immune pathways by interacting with toll-like receptors such as TLR2 and TLR9, stimulating dendritic cells and cytokine production. This signaling enhances T-cell differentiation and natural killer cell activity, supporting adaptive immunity. Research consistently shows it regulates both innate and adaptive immune responses rather than acting as a simple immune stimulant.

Does Thymosin Alpha-1 improve vaccine response?

Thymosin Alpha-1 enhances immune function by improving antigen presentation and activating T cells, which can strengthen vaccine responses in some studies. Research shows it supports immune cell signaling and adaptive immunity, particularly in compromised immune systems. However, its use as a vaccine adjuvant remains investigational and is not established as part of standard vaccination protocols.

How does Thymosin Alpha-1 interact with cancer cells?

Thymosin Alpha-1 influences cancer through immune-mediated mechanisms by enhancing T-cell and natural killer cell activity and improving immune surveillance. Studies show it may support antitumor responses and work alongside immunotherapy or chemotherapy. However, its direct effects on tumor cells remain under investigation, and it is not approved as a standalone cancer treatment.

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE INTENDED FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: All products sold by My Peptides are strictly intended for research and laboratory use only. These items are not designed for human or animal use or consumption. They are not classified as drugs, food, cosmetics, or medicinal products and must not be mislabeled or misused as such. By purchasing from our website, buyers acknowledge and accept all risks associated with handling these materials. The information and articles provided on this website are purely for educational and informational purposes. Handling and usage of these products should be carried out exclusively by qualified professionals.